about
Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasiaHigh expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.Specific human granulocyte-macrophage colony-stimulating factor antagonists.Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cellsBlastic leukaemias (AML): a biologist's view.The possible diagnostic and prognostic use of systemic chemokine profiles in clinical medicine—the experience in acute myeloid leukemia from disease development and diagnosis via conventional chemotherapy to allogeneic stem cell transplantation.DNA triplex formation selectively inhibits granulocyte-macrophage colony-stimulating factor gene expression in human T cells.The inducible tissue-specific expression of the human IL-3/GM-CSF locus is controlled by a complex array of developmentally regulated enhancers.Biological features of leukaemic cells associated with autonomous growth and reduced survival in acute myeloblastic leukaemia.Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia.Abnormalities of retinoblastoma gene expression in hematological malignancies.Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells.The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene.Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
P2860
Q33843736-4EA7594C-3AD9-4A9F-9F01-69AD9AEA142EQ34845224-E192EE9C-73E3-4C8D-BEB1-9275DF0E88C3Q35536111-C4E600EF-AF1D-4801-9C11-60BB56FDBF46Q37369057-080C3382-FFDD-4C90-BEA1-562DD75CC26CQ38026774-43383813-AC65-49C6-8DF4-04046EB3DD3EQ38083604-944550C9-F308-45ED-B4B1-FFA1F92F6F3CQ38356691-CEE00EE9-034A-43FD-9543-CF180648D6B8Q39268646-422D3E97-7E5C-4D7F-914D-05B081235472Q40507901-6D1291C5-7923-471D-A020-799217A53717Q40526838-7437C001-7207-4E23-A76C-57F990280E08Q40958157-F5D95C9A-96B8-4033-81ED-C1C129B921D0Q41483255-15C20C90-7FC5-4DFE-9D13-C6A4B1EBFB42Q45750343-382AB75A-45A1-4047-91B8-79C4BF44E458Q47951260-492FBD87-5C74-4BD2-9638-53C7B7BB4CBD
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Autocrine growth factors and leukaemic haemopoiesis.
@ast
Autocrine growth factors and leukaemic haemopoiesis.
@en
type
label
Autocrine growth factors and leukaemic haemopoiesis.
@ast
Autocrine growth factors and leukaemic haemopoiesis.
@en
prefLabel
Autocrine growth factors and leukaemic haemopoiesis.
@ast
Autocrine growth factors and leukaemic haemopoiesis.
@en
P1433
P1476
Autocrine growth factors and leukaemic haemopoiesis.
@en
P2093
Russell NH
P304
P356
10.1016/0268-960X(92)90026-M
P577
1992-09-01T00:00:00Z